China Type Testing Medical Devices & IVDs

Type testing, also called in country testing, is a critical step in the regulatory process for medical devices and IVDs seeking approval in China. When conducted in accordance with national standards set by the National Medical Products Administration (NMPA), type testing verifies that products meets performance, safety, and quality requirements before they can be legally marketed.

This process ensures that products are safe for patients and comply with China’s stringent regulatory framework. The final testing report is an essential document reviewed by authorities for product approval.

Chinese testing
Accredited testing institutes
Testing methods

IVD & Medical Device Testing

Medical devices and IVDs must be tested at an NMPA accredited laboratory, where the product samples are tested against the applicable GB and YY standards. These tests check a variety of aspects including, but not limited to, electrical safety (especially for electrical medical equipment), biocompatibility, mechanical performance, and electromagnetic compatibility.

The tests depend on the product’s intended use and classification. The specific test report from these tests forms an integral part of the required documents for the registration application with the NMPA, emphasizing the role of the testing report as a critical document in the registration application. This includes demonstrating conformity to the Product Technical Requirements specific to each product type.

It is also important to include certificates of critical components as part of the necessary documentation for ensuring safety and usability.

Regulatory changes in October 2021 allowed for self-testing under certain conditions, however the process remains complex and is primarily only feasible for large domestic manufacturers with the resources to generate to a self testing report in compliance with NMPA guidelines. For an overseas manufacturer, compliance is easier when working a certified NMPA laboratory, especially given language barriers and the evolving nature of China's testing requirements.

Due to these language issues, complex regulations, and stringent testing measures, many manufacturers hire local regulatory experts such as Cisema, who handle and oversee the type testing process for faster and more accurate results.

How Long Does Type Testing Take?

The duration of type testing in China typically ranges from 4 to 6 months under standard conditions. However, if biocompatibility testing is required, the process may extend to up to 9 months. The high demand for testing services can lead to long waiting times for type testing dates.

Several factors can influence the overall timeline, including:

Device complexity

More complex products may require additional tests, increasing the duration.

Scope of testing

The number and type of tests required, based on applicable GB and YY standards, impact the timeframe.

Laboratory workload

The testing laboratory’s current capacity and schedule can affect processing times.

Documentation & sample submission

Delays in submitting required documents or product samples can prolong the process.

Responsiveness to laboratory questions

From a practical perspective, labs often have testing questions about the specific product.

Biocompatibility tests

These are the only test reports the NMPA accepts from non-NMPA-certified laboratories outside China

Our China Type Testing Services for Medical Devices & IVDs

We provide end-to-end support for Class ii and Class iii medical device and IVD type testing in NMPA-accredited laboratories. Local testing institutes play a crucial role in the evaluation of products, and their involvement is essential to ensure thorough and accurate testing processes. To encounter any difficult testing scenarios, we send our experienced test engineers on-site to supervise all testing in China to guarantee accurate and reliable results.

Our services include:

Pre-Testing Consultation

Assessment of product specifications and regulatory requirements
Identification of applicable testing standards and test items
Guidance on sample preparation and documentation requirements
Evaluation if existing biocompatibility test reports according to ISO-10993 comply with the latest requirements of China NMPA e.g. GB/T 16886
Pre-tests to simulate challenging testing scenarios before the actual type testing
Outlining of product components in the documentation required for compliance during product design and testing processes

Coordination with National Medical Products Administration (NMPA)-Accredited Laboratories

Selection of suitable laboratories based on device category and test scope
Scheduling and coordinating all testing activities
Ensuring proper submission of product samples and technical documents
Understanding the importance of the NMPA as the regulatory body responsible for overseeing the safety, efficacy, and quality of medical devices in China
Addressing the challenges associated with coordinating different testing units that often operate sequentially, leading to potential delays

On-Site Supervision by Test Engineers

Our test engineers are present on-site to oversee the entire testing process. They ensure that all testing details are meticulously addressed during the type testing procedures, facilitating comprehensive evaluations. This includes interactions with reviewers to confirm that all protocols are followed correctly.

Monitoring test procedures to ensure compliance with NMPA protocols
Addressing technical issues and ensuring accurate test execution
Immediate troubleshooting of unexpected testing challenges
Conducting a technical review to ensure compliance with NMPA protocols and address any issues that arise during testing

Test Progress Tracking & Testing Report

Regular updates on testing progress and milestones
Transparent communication of any deviations or additional requirements
Collection and verification of test data and preliminary results

Interpretation of Test Results

Comprehensive review and analysis of test outcomes
Identification of potential non-conformities and recommendations for corrective actions
Clarification of technical terminology and regulatory implications

Documentation & Certification Support

Compilation of final testing reports in compliance with NMPA standards
Assistance with obtaining official test certificates required for product registration
Ensuring proper documentation for future regulatory inspections

Post-Testing Advisory

Guidance on next steps in the NMPA registration process
Recommendations for product modifications if required
Support in addressing test-related inquiries from regulatory authorities

Request a Proposal from Our Life Sciences Team for Type Testing Your Medical Device or IVD in China

Let Cisema help turn your plans into reality.

Request Proposal

Useful Articles

View More

How China IVD Risk Classification Determines Your NMPA Registration Pathway

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

July 13, 2026
How China IVD Risk Classification Determines Your NMPA Registration Pathway

A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understand South Korea’s medical device regulations, from classification to approval and post-market compliance.

July 10, 2026
A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management

Learn how MFDS’s Digital Medical Product Safety Management Roadmap will shape future compliance requirements for digital medical products in Korea.

July 10, 2026
Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management
Stock photo of a Korean man in his early 30s sitting comfortably in a bright, contemporary apartment in South Korea, casually reviewing a health monitoring app on his smartphone while wearing a small continuous glucose monitor (CGM) sensor on his arm.

What Is the MFDS? Understanding South Korea’s Medical Device Authority

Learn how South Korea’s Ministry of Food and Drug Safety regulates medical devices, including classification, application review and post-market duties.

July 10, 2026
What Is the MFDS? Understanding South Korea’s Medical Device Authority

Explained: South Korea Medical Device Classification (Class I, II, III, & IV)

Learn how South Korea medical device classification works under the MFDS.

July 10, 2026
Explained: South Korea Medical Device Classification (Class I, II, III, & IV)
Stock photo of an adult South Korean patient wearing a continuous glucose monitor (CGM) on the upper arm during a routine appointment in a modern hospital outpatient clinic

China NMPA Fee Catalogue for Drugs & Medical Devices

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.

July 10, 2026
China NMPA Fee Catalogue for Drugs & Medical Devices
Previous
Previous

Explore Related Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive.

China Medical Device Registration

We guide you through every step of Class i filings and Class ii and iii registrations. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.

Learn more

China NMPA IVD Registration

We support you through every stage of the China IVD registration and filing process, ensuring compliance with NMPA regulations. From choosing the best market entry strategy to handling regulatory requirements, we make the process as smooth as possible.

Learn more

NMPA Legal Agent

We are your authorized representative in China, and fulfill your registrations and filings as well as ensuring compliance with quality and PMS requirements.

Learn more

NMPA Clinical Evaluation Report

Clinical Evaluation Reports can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA compliant CERs.

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, we have a variety of solutions to meet your needs.

Learn more

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

Learn more

Latest Insights

View More

China Expands MRI Registration Requirements Under New 2026 Review Guideline

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

July 16, 2026
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Chinese male MRI technician in a clinical, sterile medical imaging room. The man has a warm, focused expression and is wearing a dark blue medical-style t-shirt

China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

July 14, 2026
China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

July 2, 2026
Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration
A clinical trial in Hainan, China, inside a clinical research consultation room at a  hospital. A Chinese doctor in a white lab coat seated across from an adult study participant discussing routine trial procedures, a second researcher reviewing data.

Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026

MDA will issue only electronic establishment licenses, affecting medical device manufacturers, importers, and distributors.

June 11, 2026
Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026
stock photograph of a patient and healthcare professional in a modern Malaysian hospital cardiology department

Indonesia Removes IDAK Renewals Under New Licensing Framework

Indonesia removes IDAK renewals, mandates SDAK and IPAK transitions, and shortens correction timelines under risk-based licensing.

June 11, 2026
Indonesia Removes IDAK Renewals Under New Licensing Framework

Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices

New MDA guidance introduces a risk-based framework for managing post-registration medical device changes, including software updates and SaMD.

June 11, 2026
Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices
stock photo of an advanced handheld vein visualization device being used by a Malaysian nurse in a modern private hospital treatment room in Malaysia
Previous
Previous

Get in Touch with Our Life Sciences Team

And discover how we can support you in undertaking the Type Testing for your medical device or IVD in China.

Request Proposal